Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1969;40(2):295–300.

USOL-D bac (type 3 poliovirus) vaccine studies.

PMCID: PMC2554615  PMID: 5306547

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHUMAKOV M. P., DZAGUROV S. G., LASHKEVICH V. A., GRACHEV V. P., MIRONOVA L. L., RALF N. M., ELBERT L. B. METODY I REZUL'TATY IZGOTOVLENIIA ZHIVO I POLIOMIELITNO I VAKTSINY, NE SODERZHASHCHE I PRIMESE I VAKUOLIZIRUIUSHCHEGO VIRUSA (OB40-SV40) Vopr Virusol. 1963 Jul-Aug;29:445–449. [PubMed] [Google Scholar]
  2. Janda Z., Adam E., Vonka V. Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch. 1967;20(1):87–98. [PubMed] [Google Scholar]
  3. SIMON J. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS. Arch Gesamte Virusforsch. 1965;15:220–233. [PubMed] [Google Scholar]
  4. Simon J., Vonka V., Janda Z. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch. 1965;15(5):681–689. [PubMed] [Google Scholar]
  5. Unterharnscheidt F., Simon J. Die Neurovirulenz eines neuen attenuierten Poliovirus Typ 3 (USOL-D) im Affenversuch. Naturwissenschaften. 1965 Sep;52(17):502–502. doi: 10.1007/BF00646594. [DOI] [PubMed] [Google Scholar]
  6. VONKA V., JANDA Z., SIMON J., ADAM E., ZAVADOVA H., STAREK M. PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY. Arch Gesamte Virusforsch. 1965;15:234–243. [PubMed] [Google Scholar]
  7. VONKA V., JANDA Z., SIMON J. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS. Arch Gesamte Virusforsch. 1964 Jun 17;14:599–610. doi: 10.1007/BF01555117. [DOI] [PubMed] [Google Scholar]
  8. Vonka V., Janda Z., Simon J., Adam E., Stárek M. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol. 1967;9:204–255. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES